Flu vaccinations 2018: guidance and planning clinicsPublished: 3rd October 2018
The new and extended flu vaccinations are currently being rolled out across the UK. Clinics this year will be more complex to plan than in previous years with different injections for different ages and a staggered supply of vaccine.
With appropriate planning, all patients should be able to be offered protection before the flu season starts. The latest clinical recommendations and programme delivery guidance published by NHS England can help you and your team implement the changes.
This year, three types of flu vaccine will be used in the flu programme. This will benefit patients by ensuring that they have the most suitable vaccine that gives them the best protection against flu. The three vaccines are:
- Adjuvanted trivalent flu vaccine (aTIV) – This is licensed for people aged 65 years and over and is the vaccine recommended by the Joint Committee on Vaccination and Immunisations (JCVI) for this age group. The deliveries of aTIV to practices and pharmacies will be staged between September and early November.
- Quadrivalent vaccine (QIV) – This is recommended for children aged from 6 months to 2 years and in adults from 18 years to less than 65 years of age who are at increased risk from flu because of a long term health condition.
- Live attenuated influenza vaccine (LAIV) – In general practice and via school based programmes. This is a nasal spray and is licensed for children and young people from 2 years old to less than 18 years of age. The age groups targeted in England for this vaccine in 2018/19 are two and three year olds (through their GP surgery) and school aged children in reception class through to Year 5 (through schools). If LAIV is clinically contraindicated QIV is used in this age group. Both are ordered centrally from Vaccine Supply.
Add to favourites
Comments are closed.